Golden helpers

Nanoparticles could allow for faster, better medicine

Gold nanoparticles could help make drugs act more quickly and effectively, according to new research conducted at Binghamton University, State University of New York.

Nanoparticles are microscopic particles that are bigger than atoms but smaller than what the eye can see. They are unique for their large surface area-to-volume ratio and their fairly ubiquitous nature. A new study, co-conducted by Binghamton University Assistant Professor of Biomedical Engineering Amber Doiron, is one of the first of its kind to look deeper into these nanoparticles in regards to health. “Nanoparticles are a huge area of research in the scientific community right now. However, they’re not yet well understood for their impact on human health,” said Doiron.

Binghamton University Assistant Professor of Biomedical Engineering Amber...
Binghamton University Assistant Professor of Biomedical Engineering Amber Doiron, is one of the first of its kind to look deeper into these nanoparticles in regards to health.
Credit: Binghamton University, State University of New York

“Nanoparticles have unique properties and, because of that, are used in many applications. They’re in your food and may get into your bloodstream through environmental exposure. Eventually, they may be used for helping to get drugs to tissues or as imaging agents. We wanted to investigate how nanoparticles interact with human cells,” added Doiron.

Doiron and her team looked specifically at the effects that gold nanoparticles have on the health of a cell. They found that nanoparticles can change cells, but only if the particles are a very specific size. “The nanoparticles have to be around 20 nanometers. Nothing bigger or smaller worked,” said Doiron.

It has to be exact, otherwise changing the permeability of veins too much could be extremely dangerous

Amber Doiron

Their research found that when the cells that line arteries or veins are exposed to these nanoparticles, the vascular permeability changes. This could potentially help in more effective medication delivery. However, the researchers are also aware of some limitations to nanoparticles being used in this way. “It has to be exact, otherwise changing the permeability of veins too much could be extremely dangerous,” said Doiron.


Source: Binghamton University, State University of New York

21.11.2017

Read all latest stories

Related articles

Photo

Crossing the blood-brain barrier

Nanoparticle drug-delivery system to treat brain disorders

In the past few decades, researchers have identified biological pathways leading to neurodegenerative diseases and developed promising molecular agents to target them. However, the translation of…

Photo

Triple-negative breast cancer

Target validation for drug development against aggressive breast cancer

At around 30.5 percent, breast cancer is the most common cancer among women in countries of the industrialized world. The number of cases has doubled since the 1980s: about 69,000 times a year women…

Photo

Reducing side effects

Nanohybrid vehicles to deliver drugs into the human body

Researchers in The University of Texas at El Paso’s (UTEP) Department of Chemistry and Biochemistry have developed a nanohybrid vehicle that can be used to optimally deliver drugs into the human…

Related products

Alsachim, a Shimadzu group company – Dosinaco

Clinical Chemistry

Alsachim, a Shimadzu group company – Dosinaco

Alsachim, a Shimadzu Group Company
ASP Lab Automation – Recapper KapSafe

Sample Processing

ASP Lab Automation – Recapper KapSafe

ASP Lab Automation AG
ASP Lab Automation – Tube Sorter SortPro

Sample Processing

ASP Lab Automation – Tube Sorter SortPro

ASP Lab Automation AG
Beckman Coulter – Access Interleukin-6 (IL-6)

Immunoassays

Beckman Coulter – Access Interleukin-6 (IL-6)

Beckman Coulter, Inc.
Beckman Coulter – DxA 5000

Sample Processing

Beckman Coulter – DxA 5000

Beckman Coulter, Inc.
Beckman Coulter – DxH 500 Family

Blood Cell Counter

Beckman Coulter – DxH 500 Family

Beckman Coulter, Inc.
Subscribe to Newsletter